The report criticized the electronic health record incentive programs and the government’s efforts to foster EHR adoption and promote interoperability.
In the letter, CHIME said that while it has voiced similar concerns regarding the EHR incentive programs, it believes the program has helped drive health IT adoption, and advance interoperability.
CHIME also noted the need for an extension of stage 2 to give providers the opportunity to optimize their EHR technology and achieve the benefits of stage 1 and stage 2, and to give vendors time to develop and deliver needed technology to correspond with stage 3. CHIME’s proposal for an extension would result in stage 2 continuing in 2016 and stage 3 being pushed back to 2017.
More Articles on CHIME:
CHIME Names Russell Branzell CEO
CHIME Suggests Changes to CMS Proposed Stage 2 Meaningful Use Rule
CHIME Expresses Concern Over Accuracy of EHR’s Clinical Quality Reports
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
